Latest Tweets
Department of Health and Social Care (DHSC) has issued a supply disruption notification for Berinert (Human C1 Esterase inhibitor) 500IU powder and solvent for injection as limited stock remains in the supply chain. Further information and management advice can be found in the alert. The DHSC Medicine Supply Team provide a monthly update on potential...
5 hours ago
Further to our news story Temporary parallel export ban issued to ensure continued supply of medicines the Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) has announced that Colestyramine sachets and Fluticasone nasules are to be added to the list of medicines which must not be parallel exported...
1 day ago
Class 2 Medicines recall: Ranitidine 150mg and 300mg Film-Coated Tablets (Accord Healthcare)
Drug alert number: EL (19)A/40 Date issued: 5 December 2019 Accord Healthcare are recalling all unexpired stock of the products listed below from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity Nnitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential. Product PL Number Ranitidine 150mg Film-Coated Tablets 20075/0063 Ranitidine 300mg...
1 day ago
The Pharmaceutical Needs Assessment (PNA) looks at the current provision of pharmaceutical services across the relevant Health and Wellbeing Board area. The PNA is a key document which will be used by NHS England to inform decisions regarding applications for new or changes to existing pharmaceutical services.
Local authorities have now published new PNAs for 2018-2021 which can be found below.
Last Updated: 19th February 2019